Ad
related to: surgical cure for diabetes insipidus in humans treatment center phone number
Search results
Results From The WOW.Com Content Network
Desmopressin, sold under the trade name DDAVP among others, is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. [1] In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. [ 1 ]
Central diabetes insipidus is typically an acquired disorder. [9] The following conditions may result in central diabetes insipidus: [10] Surgery - Neurosurgery, typically in the sellar or suprasellar area, can induce central diabetes insipidus. [11] In most neurosurgery-related situations, central diabetes insipidus is temporary. [12]
[18] [47] [48] This condition affects around 70% of the patients with WSF1 mutation (WFS2 mutation does not typically associate with diabetes insipidus). [10] [15] Diabetes insipidus occurs around the age of 14 but the condition is often diagnosed late. Therefore, there is a high variability in the onset age.
Diabetes insipidus (DI) is a condition characterized by large amounts of dilute urine and increased thirst. [1] The amount of urine produced can be nearly 20 liters per day. [ 1 ] Reduction of fluid has little effect on the concentration of the urine. [ 1 ]
The act authorized diabetes research and training centers, and an intergovernmental diabetes coordinating committee that included representatives from the NIAMDD and six other NIH Institutes. January 1975 —The National Arthritis Act of 1974 (P.L. 93—640) was signed into law to further research, education, and training in the field of ...
Studies with monkeys show that injecting high-insulin-producing forms of these cells into the animals can “cure” type-1 diabetes for about six months. Human trials are underway.
Joslin Diabetes Center is the world's largest diabetes research center, diabetes clinic, and provider of diabetes education. It is located in the Longwood Medical and Academic Area in Boston , Massachusetts , United States.
Persons with nephrogenic diabetes insipidus must consume enough fluids to equal the amount of urine produced. Any underlying cause such as high blood calcium must be corrected to treat nephrogenic diabetes insipidus. The first line of treatment is hydrochlorothiazide and amiloride. [10] Patients may also consider a low-salt and low-protein diet.